Q2 2025 13F Holders as of 30 Jun 2025
-
Type / Class
-
Equity / Common Stock, par value $0.005 per share
-
Shares outstanding
-
110,002,045
-
Number of holders
-
0
-
Total 13F shares, excl. options
-
0
-
Shares change
-
-1,488,245
-
Total reported value, excl. options
-
$0
-
Value change
-
-$264,175
-
Number of sells
-
-25
Significant Holders of Ernexa Therapeutics Inc. - Common Stock, par value $0.005 per share (ERNA) as of Q2 2025
25 filings reported holding ERNA - Ernexa Therapeutics Inc. - Common Stock, par value $0.005 per share as of Q2 2025.
Ernexa Therapeutics Inc. - Common Stock, par value $0.005 per share (ERNA) has 0 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 0 shares
of 110,002,045 outstanding shares and own 0% of the company stock.
Largest 10 shareholders include Vanguard Personalized Indexing Management, LLC (0 shares), Sippican Capital Advisors (0 shares), Naviter Wealth, LLC (0 shares), Activest Wealth Management (0 shares), Avidian Wealth Enterprises, LLC (0 shares), ASSETMARK, INC (0 shares), MONTAG A & ASSOCIATES INC (0 shares), SBI Securities Co., Ltd. (0 shares), GEODE CAPITAL MANAGEMENT, LLC (0 shares), and Cypress Point Wealth Management, LLC (0 shares).
This table shows the top 0 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.